EMEA-003449-PIP01-23
EMEA-003449-PIP01-23
EMEA-003449-PIP01-23
EMEA-002830-PIP01-20
EMEA-003450-PIP01-23
EMEA-003456-PIP01-23
EMEA-003347-PIP01-22
EMEA-003461-PIP01-23
Orphan designation: A combination of H-Lys-Lys-Gly-Pro-Arg-Cys(SH)-Leu-Thr-Arg-Tyr-Tyr-Ser-Ser-Phe-Val-Asn-Met-Glu-Gly-Lys-Lys-OH and H-Lys-Lys-Gly-Asp-Asn-Ile-Met-Val-Thr-Phe-Arg-Asn-Gln-Ala-Ser-Arg-Pro-Tyr-Gly-Lys-Lys-OH Treatment of haemophilia A, 19/11/2014 Positive
Orphan designation: 7-Ethyl-10-hydroxycamptothecin Treatment of glioma, 11/11/2024 Positive
Orphan designation: Coramitug Treatment of ATTR amyloidosis, 11/11/2024 Positive
Orphan designation: Mesenchymal stem cells-derived small extracellular vesicles loaded with siRNA against phosphatase and tensin homolog Treatment of spinal cord injury, 11/11/2024 Positive